SOCS3 and systemic lupus erythematosus: discovered that SOCS3 expression within capsule cells might exert protective effects against glomerulonephritis development by suppressing IL-6 production within these cells while inhibiting autoantibody generation through studies conducted on imiquimod-induced lupus mice models (75).